We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RVXCF market cap is 10.06M. The company's latest EPS is USD -0.0616 and P/E is -0.97.
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 74k | 109k | 57k |
| Operating Income | -22.65M | -9.41M | -15.85M | -12.71M | -5.18M |
| Net Income | 118.03M | 1.64M | -24.77M | -3.61M | -16.74M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.38M | 10.71M | 9.98M | 8.12M | 6.52M |
| Total Liabilities | 75.49M | 50.6M | 69.85M | 67.4M | 80.99M |
| Total Equity | -64.11M | -39.9M | -59.87M | -59.28M | -74.47M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.34M | -2.93M | -8.02M | -3.54M | -2.61M |
| Investing | -576k | -284k | -833k | -473k | -516k |
| Financing | 10.17M | 3.3M | 8.81M | 4.06M | 3.09M |
| Market Cap | 10.06M |
| Price to Earnings Ratio | -0.97 |
| Price to Sales Ratio | 300 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -0.22 |
| Dividend Yield | - |
| Shares Outstanding | 271.92M |
| Average Volume (1 week) | 3.51k |
| Average Volume (1 Month) | 5.9k |
| 52 Week Change | -63.00% |
| 52 Week High | 0.10 |
| 52 Week Low | 0.034 |
| Spread (Intraday) | 0.02 (35.91%) |
| Company Name | Resverlogix Corporation (PK) |
| Address |
4820 richard road s.w calgary, alberta T3E 6L1 |
| Website | https://www.resverlogix.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
